Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.1B | 4.0B | 4.2B | 3.8B |
| Cost of revenue | 1.8B | 1.7B | 1.7B | 1.6B |
| Gross profit | 2.3B | 2.3B | 2.5B | 2.2B |
| Operating expense | ||||
| Research & development | 517M | 491M | 492M | 498M |
| Selling general and admin | 472M | 446M | 428M | 465M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.3B | 1.4B | 1.6B | 1.2B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 128M | 130M | 131M | 131M |
| Other income expense | 80M | 112M | 131M | 130M |
| Pretax income | 1.3B | 1.4B | 1.6B | 1.2B |
| Tax provision | 97M | 154M | 192M | 120M |
| Net income | 1.2B | 1.2B | 1.4B | 1.1B |
| Basic EPS | 1.3 | 1.3 | 1.5 | 1.2 |
| Diluted EPS | 1.3 | 1.3 | 1.5 | 1.2 |
| Basic average shares | 1.0B | 1.0B | 1.0B | 1.0B |
| Diluted average shares | 1.0B | 1.0B | 1.0B | 1.0B |
| EBITDA | 1.8B | 1.9B | 2.1B | 1.8B |
| Net income from continuing op. | 1.2B | 1.2B | 1.4B | 1.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | 6M | 7M | — |